Taiwan Liposome (TLC) Jumps Above 30% as It Attains Approval to Initiate COVID-19 Treatment Trial
Australian and Taiwan approval for TLC19 comes after the acceptance of TLC’s investigational new drug application. Shares of Taiwan Liposome
Menu